loadpatents
name:-0.015826940536499
name:-0.0081028938293457
name:-0.00052690505981445
Folmer; James Patent Filings

Folmer; James

Patent Applications and Registrations

Patent applications and USPTO patent grants for Folmer; James.The latest application filed is for "metabotropic glutamate receptor isoxazole ligands and their use as potentiators".

Company Profile
0.9.12
  • Folmer; James - Wilmington DE US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators--842
Grant 8,377,940 - Clayton , et al. February 19, 2
2013-02-19
Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842
Grant 8,377,939 - Clayton , et al. February 19, 2
2013-02-19
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators--286
Grant 8,148,372 - Cacciola , et al. April 3, 2
2012-04-03
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators
Grant 7,888,353 - Cacciola , et al. February 15, 2
2011-02-15
Metabotropic Glutamate Receptor Isoxazole Ligands And Their Use As Potentiators
App 20100324044 - Cacciola; Joseph ;   et al.
2010-12-23
Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
App 20100317662 - Cacciola; Joseph ;   et al.
2010-12-16
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators
App 20100280082 - Clayton; Joshua ;   et al.
2010-11-04
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators - 842
App 20100267740 - Clayton; Joshua ;   et al.
2010-10-21
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841
Grant 7,799,792 - Clayton , et al. September 21, 2
2010-09-21
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
Grant 7,790,760 - Cacciola , et al. September 7, 2
2010-09-07
Metabotropic glutamate receptor isoxazole ligands and their use as potentiators--286
Grant 7,781,434 - Cacciola , et al. August 24, 2
2010-08-24
Spirocyclopropyl Piperidine Derivatives
App 20100168105 - Bernstein; Peter ;   et al.
2010-07-01
Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
App 20100022545 - Cacciola; Joseph ;   et al.
2010-01-28
Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators 286
App 20090306158 - Cacciola; Joseph ;   et al.
2009-12-10
Metabotropic Glutamate Receptor Oxadiazole Ligands and Their Use as Potentiators 841
App 20080306088 - Clayton; Joshua ;   et al.
2008-12-11
Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842
App 20080306077 - Clayton; Joshua ;   et al.
2008-12-11
Piperidine Derivatives as Histamine H3 Receptor Ligands
App 20080064706 - Folmer; James ;   et al.
2008-03-13
Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
App 20070249618 - Folmer; James ;   et al.
2007-10-25
Novel piperidine derivative for the treatment of depression
App 20070191358 - Folmer; James ;   et al.
2007-08-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed